Peer Review reports
From: The change rate in serum nitric oxide may affect lenvatinib therapy in hepatocellular carcinoma
Original Submission | ||
---|---|---|
28 Feb 2022 | Submitted | Original manuscript |
1 Apr 2022 | Reviewed | Reviewer Report |
2 Apr 2022 | Reviewed | Reviewer Report |
26 Apr 2022 | Author responded | Author comments - Haruki Uojima |
Resubmission - Version 2 | ||
26 Apr 2022 | Submitted | Manuscript version 2 |
29 Apr 2022 | Author responded | Author comments - Haruki Uojima |
Resubmission - Version 3 | ||
29 Apr 2022 | Submitted | Manuscript version 3 |
30 Apr 2022 | Author responded | Author comments - Haruki Uojima |
Resubmission - Version 4 | ||
30 Apr 2022 | Submitted | Manuscript version 4 |
9 May 2022 | Author responded | Author comments - Haruki Uojima |
Resubmission - Version 5 | ||
9 May 2022 | Submitted | Manuscript version 5 |
25 May 2022 | Reviewed | Reviewer Report |
26 May 2022 | Reviewed | Reviewer Report |
12 Jul 2022 | Author responded | Author comments - Haruki Uojima |
Resubmission - Version 6 | ||
12 Jul 2022 | Submitted | Manuscript version 6 |
13 Jul 2022 | Author responded | Author comments - Haruki Uojima |
Resubmission - Version 7 | ||
13 Jul 2022 | Submitted | Manuscript version 7 |
4 Aug 2022 | Reviewed | Reviewer Report |
Resubmission - Version 8 | ||
Submitted | Manuscript version 8 | |
Publishing | ||
5 Aug 2022 | Editorially accepted | |
23 Aug 2022 | Article published | 10.1186/s12885-022-10002-x |
You can find further information about peer review here.